Dance Biopharm Holdings appoints medical device commercialization expert Matt Jennings as Board Director SAN FRANCISCO, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Dance Biopharm Holdings, Inc. ("Dance"), a private biotechnology company focused on developing transformational healthcare solutions to treat...

Dance Biopharm Holdings announces the appointment of Anne Whitaker as Chief Executive Officer SAN FRANCISCO, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Dance Biopharm Holdings Inc. ("Dance"), a private biotechnology company focused on developing transformational healthcare solutions to treat...

Dance Biopharm Holdings Completes over $24 Million Private Financing SAN FRANCISCO, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Dance Biopharm Holdings Inc. (“Dance”), a privately-held biotechnology company focused on the development of Dance 501, a proprietary ‘soft-mist’...